Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

March 21, 2018

The decision by Italian authorities to seize Open Arms, a rescue vessel belonging to the Spanish NGO Proactiva, shortly after its crew rescued and disembarked 216 people in the Central Mediterranean on Sunday is the latest in a long series of actions obstructing non-governmental organizations from carrying out lifesaving rescue operations at sea, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today.

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

November 20, 2017

Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine Prevnar13 (PCV13), said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF). MSF is set to argue tomorrow in the High Court of Delhi that it should be overturned because the patent doesn’t meet the standards laid out in India’s Patents Act.

October 13, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières(MSF) filed a petition before the High Court of Delhi today to overturn a patent granted to Pfizer pharmaceutical corporation on the pneumococcal conjugate vaccine (PCV).

September 01, 2017

Libyan authorities must immediately end the arbitrary detention of refugees, asylum-seekers, and migrants, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, decrying the dire, unhealthy, and abusive conditions in detention centers.

August 22, 2017

Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that protects both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the U.S. pharmaceutical corporation Pfizer.

August 12, 2017

Libyan authorities have announced the establishment of a search and rescue zone and restricted access to humanitarian vessels in international waters off the Libyan coast. Due to security concerns, restrictions on independent humanitarian assistance, and the increasing blockade trapping migrants within Libya, Doctors Without Borders/Médecins Sans Frontières (MSF) has decided to temporarily suspend the search and rescue activity of its ship, Prudence.

June 26, 2017

As U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet at the White House today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that U.S. pressure on India to change its drug regulatory and patent system could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines. As an international medical humanitarian organization that relies on affordable generic medicines produced in India to run its medical programs in more than 60 countries, MSF urged Modi to stand strong and protect India’s role as the “pharmacy of the developing world.”

May 24, 2017

While teams from the aid organizations Doctors Without Borders/Médecins Sans Frontières (MSF) and SOS Méditerranée attempted to rescue people from boats in distress in the Mediterranean Sea on May 23, the Libyan coast guard approached the boats, intimidated the passengers and then fired gunshots into the air, threatening people's lives and creating mayhem, MSF said today.

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

Pages